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Different sugar-grafted liposomes were prepared and tested against experimental
leishmaniasis in vivo using the classical drug pentamidine isethionate and its methoxy
derivative. Both the drugs, when encapsulated in sugar-grafted liposomes were found
to be more potent in comparison to normal liposome-encapsulated drug or to the
free drug. Moreover, the mannose-grafted liposomes were adjudged to be the best
in lowering of spleen parasite load in comparison with those bearing glucose or
galactose. When encapsulated in mannose-grafted liposomes the therapeutic efficacy
of pentamidine isethionate was found to be better than that of its methoxy derivative,
although the latter seemed to be less toxic than the pentamidine isethionate itself.
Introduction
Targeting of drug directly to the macrophages, mediated by specific receptors is a
challenge not only to counter leishmaniasis but also to control a few other diseases
where the invading organisms can survive within macrophages. In an attempt to develop
delivery systems acceptable to all macrophage-associated disorders, the uptake of
glycoside-bearing liposomes by macrophages has been studied in vitro. Since, the uptape
was found to be specific for the end sugar attached to the glycoside, the possibility was
raised that glycoside-bearing liposomes might be used as systems to deliver drugs to
macrophages in vivo. Using the antileishmanial drug urea stibamine, these delivery
systems have been tested for therapeutic efficacy (Das et al., 1990) and for toxicity
(Medda et al., 1993) against experimental leishmaniasis. Mannose-grafted liposomes
were found to be most efficient in the lowering of spleen parasite load and least toxic
when compared either to the ordinary liposomes or to the free drug. Our recently
published report on hamycin intercalated in mannose-grafted liposomes also support
these findings (Banerjee, Bhaduri & Basu, 1994). In the present paper we discuss the
effective use of pentamidine isethionate and one of its derivatives in liposome-encapsu-
lated form as well as in sugar-grafted liposome-encapsulated form against experimental
leishmaniasis in hamsters. The efficacy and the toxicity of both drugs have been critically
compared and analysed.
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Methods
Chemicals
Pentamidine isethionate (PI) and methoxy pentamidine isethionate (MPI) were
prepared and their microbicidal properties were tested in vitro (Mahato et al., 1993).
Phosphatidylethanolamine (PE), cholesterol, dicetyl phosphate (DCP), different
p-aminophenyl-a-D-glycosides, glutaraldehyde and sugar specific lectins were
purchased from Sigma Chemicals (St. Louis, MO USA). All other reagents were of
analytical reagent grade.
Preparation of liposome-encapsulated pentamidine isethionate (PI) and methoxy
pentamidine isethionate (MPI)
The multilamellar liposomes were prepared using PE, cholesterol, DCP in the molar
ratio 7:2:1 as described earlier (Gregoriadis & Ryman, 1972).
PI or MPI were suspended in 2 mL PBS, pH 7.4 and used for swelling the lipid film
for 1 h at 37°C. The suspension was sonicated for 30 sec and centrifuged at 100,000g
for 30 min in a Beckman Ultracentrifuge. The pellet was washed twice in an identical
manner and suspended in a known volume of PBS. The supernatent was examined for
free, unencapsulated drug by measuring absorbance at 265 nm (epi = 12,000 M " 'cm ~'
and eMpi = 10,500 M " 'cm ~ '). The amount of drug encapsulated in the liposomes was
found to be 10% for PI and 15% for MPI, therefore the amounts of drug in the lipid
film to provide a dose of 80 mg/kg were 300 mg/mL of PI and 200 mg/mL of MPI.
Coupling of p-aminophenyl-a-D-glycosides with liposomes
The liposome-encapsulated PI or MPI were suspended in 2 mL PBS. The coupling of
the appropriate glycosides with amino group of PE-liposomes was done by using
glutaraldehyde following the published protocols (Ghosh & Bachhawat, 1980). The
presence of various sugars on the liposome surface was examined by agglutination test
using sugar specific lectins (Surolia, Ahmed & Bachhawat, 1975).
Animal experiment
Our colony of golden hamsters (Mesocricetus auratus) originally from Haffkine
Research Institute, Bombay was used to maintain Leishmania donovani, strain AG 83
from an Indian kala-azar patient, by intracardial passage every 6 weeks. Amastigotes
were isolated from spleens by the method of Looker, Bernes & Marr, (1983) with some
modification as described elsewhere (Das et al., 1990). Each animal was infected
intracardially with 2 x 1 0 * amastigotes. A group of 24 hamsters of about 80 g body
weight were infected at each time and the treatment was started after 30 days. The
animals were distributed in six groups with four in each group for the testing of free
drug and liposome-encapsulated drug with their appropriate controls: (i) the drug
encapsulated in sugar-grafted liposomes; (ii) the drug encapsulated in regular liposomes
without sugar; (iii) empty sugar-grafted liposomes; (iv) empty regular liposomes without
sugar; (v) free drug (80 mg/kg); (vi) untreated controls.
The dose given to each animal was 80 mg/kg body weight. Routinely, 6.4 mg of PI
or MPI in 5 mg lipid in 0.5 mL PBS was injected subcutaneously into each hamster
every 3 days for a total of four doses over 10 days. For free PI or MPI the same amount
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of drug (6.4mg/0.5mL PBS) was injected at each time. The animals were killed by
cervical dislocation after 4 days of the last injection. Parasite load in the spleen was
assessed from stained impression smears using the Stauber formula (Stauber Franchino
& Grun, 1958):
Total No. of amastigotes = (No. of amastigotes per host cell nucleus)
x(wt of spleen in mg) x 2 x 10'
Investigation on drug toxicity
The blood pathology, tissue histology and the specific enzyme levels related to normal
liver function are some parameters that were chosen as the toxicity indices of the drug
when tested in vivo in both free and liposome-encapsulated form. These parameters were
analysed by established clinical procedures and the levels of specific enzymes e.g.
alkaline phosphatase (AP) and serum glutamate pyruvate transaminase (SGPT) were
assayed as described before (Medda et al., 1993).
Results
Anti-leishmanial activity tested in vivo
The results of testing using free, liposome-encapsulated and sugar grafted
liposome-encapsulated forms of PI and MPI in the hamster model are expressed in
Table I. The free PI lowered the parasite load of the spleen by 18.5% whereas the
liposome-encapsulated PI reduced the same by 46.6%. The reduction of spleen parasite
load was found to be different for different sugar-grafted liposome-encapsulated PI. For
mannose-grafted liposome-encapsulated PI the reduction in spleen parasite load was
Table I. Effect of sugar-grafted liposome-encapsulated PI and MPI for the treatment of
experimental leishmaniasis on 30-day infected hamster model
Group
1. Infected control
2. Free-drug treated
3. Liposome-encapsulated
drug treated
4. Sugar-grafted liposome-
encapsulated drug treated
(i) mannose
(ii) glucose
(iii) galactose
(Parasite load
PI
13.5 ± 1.2
11.0 ± 1.0
7.2 ± 0.4
2.0 ±0.1"
4.6 ± 0.3
7.4 ± 0.4
in the spleen) x 10 7
MPI
12.5 ± 1.2
10.6 ±0.8
7.8 ± 0.4
3.6 ± 0.2°
ND
ND
% Suppression of
spleen-parasite load
PI
18.5
46.6
85.1
65.9
45.1
MPI
15.2
37.0
71.2
—
—
The values are expressed as mean ± S.D. (n = 4). The suppression of spleen-parasite load by
empty liposomes (both ordinary and sugar-grafted) was about 10-12%.
Dose given to each animal each time was 80 mg/kg body weight. Routinely 6.4 mg of PI or
MPI in 5 mg lipid in 0.5 mL PBS was injected into each hamster each time every 3 days for a
total of four doses over 10 days. For free PI/MPI, the same amount of drug (6.4 mg/0.5 mL PBS)
was injected at each time.
'P < 0.001 compared with infected control.
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Table II. The effect of sugar-grafted liposome-encapsulated drug(s) on specific enzymes level
related to normal liver-function
Serum glutamate
Alkaline phosphatase0 pyruvate transaminase*
Groups PI MPI PI MPI
1.
2.
3.
4.
Infected control
Free-drug treated
Liposome-encapsulated
drug treated
Sugar-grafted liposome-
encapsulated drug treated
12.7
20.6
14.0
13.6
±
±
±
±
3.0
5.9
2.2
3.0
8.8
10.6
9.6
9.5
+
±
±
±
0.9
0.1
0.4
0.5
42.0
75.0
55.2
43.7
±
±
±
±
4.0
5.7
6.1
1.7
40.2
48.3
43.7
42.9
±
±
±
±
3
0
1
2
.8
.5
.7
.6
Values are expressed as mean ± S.D (n = 4).
°|imol of p-nitrophenol released/min/dL sera. Normal level of alkaline phosphate was
3.8 ± 1.5.
h\imo\ of sodium pyruvate released/min/L sera. Normal value of SGPT was 36.3 ± 2.0.
found to be 85.1% whereas for glucose grafted liposomes, it was 65.9%. However, for
galactose-grafted liposome encapsulated PI the reduction in spleen parasite load was
about 45.1% i.e. almost the same as found for PI encapsulated in ordinary liposomes.
However, f c MPI, only mannose-grafted liposomes were used. The free MPI reduced
the spleen parasite load by 15.2%, whereas the liposome encapsulated MPI, gave a
reduction of around 37.0%. The reduction of parasite load using mannose-grafted
liposome encapsulated MPI was around 71.2%.
Assay of two specific enzymes related to normal liver function
The levels of alkaline phosphatase and glutamate pyruvate transaminase were assayed
under different conditions. The results are summarised in Table II. For both PI or
MPI, the level of alkaline phosphatase increased on treatment with free drug but the
increase was much more significant for the PI, thus showing a comparatively higher
drug toxicity than MPI. For liposome-encapsulated or sugar grafted liposome-encapsu-
lated PI (or MPI) the level of alkaline phosphatase reduced further and reached the
normal level.
The level of SGPT increased from the normal level in the free drug-treated group for
both PI and MPI. But the increase was almost twice with PI, whereas for MPI, the
increase was only 1.3 times, showing again the reduced drug toxicity in case of MPI.
For liposome-encapsulated or sugar-grafted liposome-encapsulated MPI, the level of
SGPT came down almost to the normal level. However, for PI the level remained a little
higher than normal when it was encapsulated in ordinary liposomes but came to normal
level when sugar-grafted liposomes were used.
Histological studies
Histological examination of the spleen was made after staining with eosin and
heamatoxylin. Although some histological changes were observed for the free PI
treatment, no detectable changes were noticed for either liposomal or mannose-grafted
liposomal PI. On the contrary, no such changes could be noticed for any of the three
MPI formulations.
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Discussion
Antimonials, which are notorious for their toxic effects, have remained the mainstay
for the treatment of leishmaniasis, and the second-line drugs (e.g. amphotericin B and
pentamidines) are too toxic to be used as first-line therapy on a large scale. But, very
recently, many cases clinically resistant to antimonials have been found, an alarming
situation (Banerjee et al., 1994). Meanwhile, there have been reports of the successful
use of pentamidines in the treatment of antimony-resistant leishmaniasis (Sands, Kron
& Brown, 1985). Thus, an attempt was made to search for a suitable delivery system
which could not only reduce the toxicity of the drug but also would be able to increase
its efficacy. The potential of using liposomes as a delivery system is strengthened by the
fact that both the liposomes and the leishmania parasites are taken up by the same
reticuloendothelial cells, creating an ideal situation for studying drug-parasite
interaction. Moreover, if appropriate ligands are covalently attached to liposomes,
so that they could be easily recognized by the macrophage receptors, then these
modified liposomes could possibly be used very efficiently as vehicles for site-specific
delivery. Very recently, we have synthesized several pentamidine analogues and
have already screened them for their antileishmanial activity in vitro (Mahato et al.,
1993).
Pentamidines are not only known for antileishmanial activity (Chance, 1980), but also
for their antiviral, tumoricidal, antibacterial and fungistatic properties (Bell et al., 1990).
Pentamidine analogues have very recently been used against Plasmodium falciparum and
Pneumocystis carinii pneumonia (Bell et al., 1990; Jones et al., 1990). The exact
mechanism by which pentamidine and its analogues exert various microbicidal activities
is not known, although their possible active role in the inhibition of DNA/RNA
synthesis can not be ruled out (Jones et al., 1990).
The results presented in this paper show the efficacy of both pentamidine isethionate
and its methoxy derivative when tested against reversible visceral leishmaniasis in
hamsters in the free, liposome-encapsulated and sugar-grafted liposome-encapsulated
forms. The best efficacy in terms of lowering of spleen parasite load was found when
sugar-grafted liposomes were used as the delivery vehicles. Mannose-grafted
liposomes were found to be the most efficient in comparison with either glucose or
galactose-grafted ones, the latter being the least effective. Judging from the fact that
mannose and glucose are specifically involved in the recognition of the parasites or
appropriate ligands on the macrophage surface and the galactose was least involved in
the binding process (Mukherjee Ghosh & Basu, 1988), our results, in relation to the
lowering of parasite loads using different sugar-grafted liposomes (Table I), might be
expected. However a comparison of pentamidine isethionate and its methoxy derivative,
showed the former to be more potent at equivalent drug concentration—free,
liposome-encapsulated or mannose-grafted liposome-encapsulated form, although
the methoxy derivative was found to be less toxic and thus, if delivered in appropriate
doses in such tailor-made delivery vehicles, may possibly have better applications in
clinics.
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